Biochemical, Immunological and Molecular biological studies in ALL

Acute lymphoblastic leukaemia (ALL) is a heterogeneous disease with distinct manifestations and prognostic and therapeutic implications. ALL in adults is a rare disease. The results of therapy remain unsatisfactory, and progress has been relatively slow. B-cell ALL (B-ALL) is a clonal malignant disease originated in a single cell and characterized by the accumulation of blast cells that are phenotypically reminiscent of normal stages of B-cell differentiation.

Autorentext

Walaa Fikry Elbossaty es investigadora del Departamento de Química de la Facultad de Ciencias de Damietta, Egipto. Es licenciada en química y bioquímica por la Universidad de Mansoura y doctora en bioquímica y biología molecular por la Universidad de Damietta.